HKD 8.81
(2.44%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 22.79 Million USD | 116.61% |
2022 | -137.26 Million USD | 0.44% |
2021 | -137.87 Million USD | 53.5% |
2020 | -296.53 Million USD | -339.34% |
2019 | -67.49 Million USD | -95.17% |
2018 | -34.58 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 712 Thousand USD | -92.84% |
2024 Q2 | 712 Thousand USD | 0.0% |
2023 Q4 | 9.93 Million USD | 0.0% |
2023 Q2 | 1.46 Million USD | 0.0% |
2023 Q3 | 9.93 Million USD | 580.18% |
2023 FY | 22.79 Million USD | 116.61% |
2023 Q1 | 1.46 Million USD | 104.55% |
2022 FY | -137.26 Million USD | 0.44% |
2022 Q4 | -32.08 Million USD | 0.0% |
2022 Q3 | -32.08 Million USD | 12.16% |
2022 Q2 | -36.52 Million USD | 0.0% |
2022 Q1 | -36.52 Million USD | 4.15% |
2021 Q4 | -38.1 Million USD | 0.0% |
2021 Q3 | -38.1 Million USD | -23.81% |
2021 Q1 | -30.78 Million USD | 75.19% |
2021 FY | -137.87 Million USD | 53.5% |
2021 Q2 | -30.78 Million USD | 0.0% |
2020 Q4 | -124.04 Million USD | 0.0% |
2020 Q2 | -24.15 Million USD | 0.0% |
2020 Q1 | -24.15 Million USD | -61.32% |
2020 FY | -296.53 Million USD | -339.34% |
2020 Q3 | -124.04 Million USD | -413.59% |
2019 Q3 | -14.97 Million USD | 20.19% |
2019 FY | -67.49 Million USD | -95.17% |
2019 Q4 | -14.97 Million USD | 0.0% |
2019 Q2 | -18.75 Million USD | 0.0% |
2019 Q1 | -18.75 Million USD | 0.0% |
2018 FY | -34.58 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 67.835% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | -32.157% |